NASDAQ:QCOR - Questcor Pharmaceuticals Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Questcor Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDividendEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the United States food and drug administration (FDA), for the treatment of 19 indications. Its research and development program is focused on: the evaluation of the use of Acthar for certain on-label indications; the investigation of other potential uses of Acthar for indications not FDA approved; and the expansion of its understanding of how Acthar works in the human body (pharmacology), and ultimately, its mechanisms of action in the disease states for which it is used, or may be used in the future. The Company sells Doral to pharmaceutical wholesalers, which resell Doral primarily to retail pharmacies and hospitals.Read More Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryPharmaceuticals SectorN/A Current SymbolNASDAQ:QCOR Previous Symbol CUSIP74835Y10 CIK891288 Webhttp://www.mallinckrodt.com/ Phone+1-714-7864200Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive QCOR News and Ratings via Email Sign-up to receive the latest news and ratings for QCOR and its competitors with MarketBeat's FREE daily newsletter. Questcor Pharmaceuticals (NASDAQ:QCOR) Frequently Asked Questions Has Questcor Pharmaceuticals been receiving favorable news coverage? Headlines about QCOR stock have been trending somewhat positive on Saturday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Questcor Pharmaceuticals earned a coverage optimism score of 0.8 on InfoTrie's scale. They also assigned news articles about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View the latest news aboutQuestcor Pharmaceuticals. Who are some of Questcor Pharmaceuticals' key competitors? Some companies that are related to Questcor Pharmaceuticals include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), AbbVie (ABBV), Allergan (AGN), Zoetis (ZTS), Mylan (MYL), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX) and Corcept Therapeutics (CORT). What other stocks do shareholders of Questcor Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Questcor Pharmaceuticals investors own include Baidu (BIDU), Netflix (NFLX), Mastercard (MA), Qihoo 360 Technology (QIHU), Celgene (CELG), Alphabet (GOOG), Tesla (TSLA), 3D Systems (DDD), Michael Kors (KORS) and First Solar (FSLR). What is Questcor Pharmaceuticals' stock symbol? Questcor Pharmaceuticals trades on the NASDAQ under the ticker symbol "QCOR." What is Questcor Pharmaceuticals' official website? The official website for Questcor Pharmaceuticals is http://www.mallinckrodt.com/. How can I contact Questcor Pharmaceuticals? Questcor Pharmaceuticals' mailing address is 1300 N Kellogg Dr Ste D, ANAHEIM, CA 92807-1965, United States. The biopharmaceutical company can be reached via phone at +1-714-7864200. MarketBeat Community Rating for Questcor Pharmaceuticals (NASDAQ QCOR)Community Ranking: 3.4 out of 5 ( )Outperform Votes: 338 (Vote Outperform)Underperform Votes: 164 (Vote Underperform)Total Votes: 502MarketBeat's community ratings are surveys of what our community members think about Questcor Pharmaceuticals and other stocks. Vote "Outperform" if you believe QCOR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QCOR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/28/2020 by MarketBeat.com StaffFeatured Article: How is diluted EPS different from basic EPS?